Literature DB >> 10742100

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

H Niwa1, J Miyazaki, A G Smith.   

Abstract

Cell fate during development is defined by transcription factors that act as molecular switches to activate or repress specific gene expression programmes. The POU transcription factor Oct-3/4 (encoded by Pou5f1) is a candidate regulator in pluripotent and germline cells and is essential for the initial formation of a pluripotent founder cell population in the mammalian embryo. Here we use conditional expression and repression in embryonic stem (ES) cells to determine requirements for Oct-3/4 in the maintenance of developmental potency. Although transcriptional determination has usually been considered as a binary on-off control system, we found that the precise level of Oct-3/4 governs three distinct fates of ES cells. A less than twofold increase in expression causes differentiation into primitive endoderm and mesoderm. In contrast, repression of Oct-3/4 induces loss of pluripotency and dedifferentiation to trophectoderm. Thus a critical amount of Oct-3/4 is required to sustain stem-cell self-renewal, and up- or downregulation induce divergent developmental programmes. Our findings establish a role for Oct-3/4 as a master regulator of pluripotency that controls lineage commitment and illustrate the sophistication of critical transcriptional regulators and the consequent importance of quantitative analyses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742100     DOI: 10.1038/74199

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  1160 in total

1.  Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.

Authors:  T Ezashi; D Ghosh; R M Roberts
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Differentiation of embryonic stem cells is induced by GATA factors.

Authors:  Junji Fujikura; Eiji Yamato; Shigenobu Yonemura; Kiminori Hosoda; Shinji Masui; Kazuwa Nakao; Jun-ichi Miyazaki Ji; Hitoshi Niwa
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

3.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 4.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

5.  Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity.

Authors:  Tetsuya S Tanaka; Tilo Kunath; Wendy L Kimber; Saied A Jaradat; Carole A Stagg; Masayuki Usuda; Takashi Yokota; Hitoshi Niwa; Janet Rossant; Minoru S H Ko
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

6.  Ectopic expression of GATA6 bypasses requirement for Grb2 in primitive endoderm formation.

Authors:  Ying Wang; Jennifer L Smedberg; Kathy Qi Cai; D Callinice Capo-Chichi; Xiang-Xi Xu
Journal:  Dev Dyn       Date:  2010-10-05       Impact factor: 3.780

7.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

8.  RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation.

Authors:  Elisa Närvä; Nelly Rahkonen; Maheswara Reddy Emani; Riikka Lund; Juha-Pekka Pursiheimo; Juuso Nästi; Reija Autio; Omid Rasool; Konstantin Denessiouk; Harri Lähdesmäki; Anjana Rao; Riitta Lahesmaa
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

9.  Widespread Mitotic Bookmarking by Histone Marks and Transcription Factors in Pluripotent Stem Cells.

Authors:  Yiyuan Liu; Bobbie Pelham-Webb; Dafne Campigli Di Giammartino; Jiexi Li; Daleum Kim; Katsuhiro Kita; Nestor Saiz; Vidur Garg; Ashley Doane; Paraskevi Giannakakou; Anna-Katerina Hadjantonakis; Olivier Elemento; Effie Apostolou
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

Review 10.  CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Authors:  Mara Cananzi; Paolo De Coppi
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.